… are significantly associated with venous thromboembolism. In particular, we have found a
statistically significant association between venous thromboembolism and obesity, diabetes …

… of venous thromboembolism were not included in this analysis. A prior systematic review and
network meta-analysis … for the secondary prevention of venous thromboembolism has been …

Background: The management of venous thromboembolism (VTE) requires an initial treatment
with unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH), followed by …

Background: The potential risk for travel-related venous thromboembolism (VTE) has become
an important public health concern because of rapid increases in long-distance travel; …

… venous thromboembolism prevention trials to evaluate the causal effect of venous
thromboembolism … the use of composite endpoints in venous thromboembolism-prevention trials …

Background People with cancer are known to be at increased risk of venous thromboembolism
(VTE), and this risk is believed to vary according to cancer type, stage of disease, and …

ContextPatients with venous thromboembolism (VTE) are susceptible to recurrent events, but
whether prolonging anticoagulation is warranted in patients with VTE remains controversial…

… higher risk of recurrent venous thromboembolism in men than in women we did a meta-analysis
of all relevant available evidence. A secondary objective of this analysis was to look for …

Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

… of hyperhomocysteinemia, its correlation with venous thromboembolism (VTE) remains
controversial. We conducted a meta-analysis of previously published studies to clarify the role of …